Gotham Asset Management’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-14,025
| Closed | -$416K | – | 1486 |
|
|
2023
Q4 | $416K | Buy |
14,025
+1,747
| +14% | +$34.8K | 0.01% | 1043 |
|
|
2023
Q3 | $195K | Sell |
12,278
-5,233
| -30% | -$87K | ﹤0.01% | 1248 |
|
|
2023
Q2 | $330K | Buy |
+17,511
| New | +$207K | 0.01% | 1090 |
|
|
2023
Q1 | – | Sell |
-15,674
| Closed | -$77.7K | – | 1410 |
|
|
2022
Q4 | $77.7K | Sell |
15,674
-2
| -0% | -$11 | ﹤0.01% | 1185 |
|
|
2022
Q3 | $75K | Sell |
15,676
-3,350
| -18% | -$17.7K | ﹤0.01% | 1139 |
|
|
2022
Q2 | $86K | Buy |
19,026
+3,652
| +24% | +$15.9K | ﹤0.01% | 1086 |
|
|
2022
Q1 | $73K | Hold |
15,374
| – | – | ﹤0.01% | 1108 |
|
|
2021
Q4 | $114K | Hold |
15,374
| – | – | ﹤0.01% | 1103 |
|
|
2021
Q3 | $87K | Sell |
15,374
-1,338
| -8% | -$7.73K | ﹤0.01% | 997 |
|
|
2021
Q2 | $110K | Sell |
16,712
-49,328
| -75% | -$344K | ﹤0.01% | 968 |
|
|
2021
Q1 | $535K | Buy |
66,040
+45,379
| +220% | +$371K | 0.02% | 660 |
|
|
2020
Q4 | $133K | Sell |
20,661
-2,465
| -11% | -$14.4K | ﹤0.01% | 958 |
|
|
2020
Q3 | $83K | Sell |
23,126
-279,703
| -92% | -$1.13M | ﹤0.01% | 987 |
|
|
2020
Q2 | $1.39M | Buy |
302,829
+199,583
| +193% | +$849K | 0.04% | 484 |
|
|
2020
Q1 | $352K | Buy |
103,246
+21,882
| +27% | +$95.7K | 0.01% | 790 |
|
|
2019
Q4 | $415K | Buy |
+81,364
| New | +$276K | 0.01% | 860 |
|
|
2017
Q4 | – | Sell |
-243,949
| Closed | -$1.87M | – | 1081 |
|
|
2017
Q3 | $1.87M | Buy |
+243,949
| New | +$1.62M | 0.03% | 521 |
|
Other funds holding IMGN
Gotham Asset Management's IMGN Position: Q1 2024 in Review
Gotham Asset Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 14,025 shares — an estimated $416K sold.
Gotham Asset Management first reported a position in IMGN in Q3 2017 and held it in 17 quarters. The position peaked at $1.87M in Q3 2017. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Gotham Asset Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Gotham Asset Management sold 14,025 Immunogen Inc shares in Q1 2024, an estimated $416K.
- Gotham Asset Management first reported a position in Immunogen Inc in Q3 2017 and held it in 17 quarters.
- Gotham Asset Management's Immunogen Inc position peaked at $1.87M in Q3 2017.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Gotham Asset Management's 13F filing for Q1 2024, filed 15 May 2024.